Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation

Kijung Kwak, Bo Yu, Robert J. Lewandowski, Dong Hyun Kim*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

With rapid advances in modern imaging, minimally invasive ablative procedures have emerged as popular alternatives to surgical removal of tumors. Tumor ablation modalities currently offered in clinical practice include microwave ablation, radiofrequency ablation, cryoablation, high-intensity focused ultrasound, and irreversible electroporation. Cryoablation, a non-heat-based method of ablation, is increasingly being used for treating various solid tumors. Accumulated comparative data of cryoablation versus heat-based ablation techniques (e.g., radiofrequency and microwave ablation) shows superior tumor response and quicker recovery time. Evolving research has demonstrated that nanocarriers may serves as excellent catalysts for the cryoablation therapy, imaging guidance, and the co-delivery of therapeutics for minimally invasive, precise, and complete treatment of cancer with immune modulation. This review article focuses on the current status of cryoablation in clinical practice, considers opportunities for enhancing therapeutic outcomes from cryoablation, and discusses new research in the field, including theranostic nanoparticles-mediated cryotherapy and combinational cryo-based immunotherapies.

Original languageEnglish (US)
Pages (from-to)2175-2204
Number of pages30
JournalTheranostics
Volume12
Issue number5
DOIs
StatePublished - 2022

Keywords

  • Ablation
  • Cryoablation
  • Image-guided therapy
  • Immunotherapy
  • Nanoparticles

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint

Dive into the research topics of 'Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation'. Together they form a unique fingerprint.

Cite this